Efficacy and Safety of Semaglutide Once-weekly Versus Sitagliptin Once-daily as add-on to Metformin in Subjects With Type 2 Diabetes (SUSTAIN - CHINA MRCT)
Clinical trial NCT03061214 · COMPLETED
Trial details
- NCT number
- NCT03061214
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-28
- Primary completion
- 2019-03-14
- Enrollment
- 868
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.